Sanofi's Phase 3 vYF yellow fever vaccine trial in children active, not recruitingNov 6Weekly roundup, 4 itemsbelumosudilcetirizine hydrochloride and pseudoephedrine hydrochloride
Sanofi's NKCE trial SAR443579 in AML halted early; results posted for terminated studyOct 23Weekly roundup, 6 itemsBayerdiclofenac
Sanofi posts SAR444881 results; adds two rilzabrutinib trials and RSV AI studyOct 2Weekly roundup, 5 itemsrilzabrutinibSanofiUpdated
Sanofi posts results across four trials; RSV toddler study OPAL ended early by sponsor decisionAug 6Weekly roundup, 4 itemsrilzabrutinibSanofi
Sanofi posts rilzabrutinib atopic dermatitis results; opens Phase 3 meningococcal vaccine trial in CJul 17Weekly roundup, 2 itemsrilzabrutinibSanofi